CVE-2026-52866 Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization
An attacker within Bluetooth range can monopolize the connection slot, preventing legitimate users from connecting to the blood glucose monitor.
- Exploited in the wild
- Not known
- Login needed
- Not needed
- Attackable
- Local or same network only
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2026-52866?
CVE-2026-52866 is a high-severity missing authorization vulnerability in Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT), published on 18 Jun 2026. It can only be exploited from the same machine or local network, with no action from the victim.
Official description
An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.
Weakness: CWE-862
Which versions are affected by CVE-2026-52866?
How do I fix CVE-2026-52866?
No fix has been published for CVE-2026-52866 yet. Limit exposure of the affected software until one is available.
Upgrade, and check permissions on every request on the server, not only in the interface. More about Missing authorization.
Is CVE-2026-52866 being exploited?
There is no known exploitation of CVE-2026-52866 in the wild and no public exploit code.
Sources
Also known as GHSA-47r7-422p-6w2p.